Will Measles Virus or Humanity Win the International “Fitness” Challenge?

Literature Cited

1. 1. 

   Lamb RA, Parks G. 2013. Paramyxoviridae. Fields’ Virology BN Fields, DM Knipe, PM Howley 957–95 Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 6th ed..
   [Google Scholar]
2. 2. 

   Progress towards regional measles elimination—worldwide, 2000–2016; 2017. Wkly. Epidemiol. Rec. 92:649–59
   [Google Scholar]
3. 3. 

   Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL et al. 2017. The basic reproduction number (R₀) of measles: a systematic review. Lancet Infect. Dis. 17:420–28
   [Google Scholar]
4. 4. 

   Van den Driessche P. 2017. Reproduction numbers of infectious disease models. Infect. Dis. Model. 2:288–303
   [Google Scholar]
5. 5. 

   Durrheim DN, Crowcroft NS, Blumberg LH 2019. Is the global measles resurgence a “public health emergency of international concern”?. Int. J. Infect. Dis. 83:95–97
   [Google Scholar]
6. 6. 

   Griffin D. 2018. Measles vaccine. Viral Immunol 31:86–95
   [Google Scholar]
7. 7. 

   Cent. Dis. Control Prev. Measles (Rubeola). Centers for Disease Control and Prevention https://www.cdc.gov/measles
   [Google Scholar]
8. 8. 

   Paniz-Mondolfi AE, Tami A, Grillet ME, Márquez M, Hernández-Villena J et al. 2019. Resurgence of vaccine-preventable diseases in Venezuela as a regional public health threat in the Americas. Emerg. Infect. Dis. 25:625–32
   [Google Scholar]
9. 9. 

   Sarkar S, Zlojutra A, Khan K, Gardner L 2019. Measles resurgence in the USA: how international travel compounds vaccine resistance. Lancet Infect. Dis. In press. https://doi.org/10.1016/S1473-3099(19)30231-2
   [Crossref] [Google Scholar]
10. 10. 

    Zimmerman LA, Muscat M, Singh S, Ben Mamou M, Jankovic D et al. 2019. Progress toward measles elimination—European region, 2009–2018. MMWR Morb. Mortal. Wkly. Rep. 68:396–401
    [Google Scholar]
11. 11. 

    Robert A, Funk S, Kucharski AJ 2019. The measles crisis in Europe—the need for a joined-up approach. Lancet 393:2033
    [Google Scholar]
12. 12. 

    Cherry J, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ Measles. Feigin and Cherry's Textbook of Pediatric Infectious Diseases Philadelphia: Elsevier, 8th ed..
    [Google Scholar]
13. 13. 

    Mekki M, Eley B, Hardie D, Wilmshurst JM 2019. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions. Dev. Med. Child Neurol. In press https://doi.org/10.1111/dmcn.14166
    [Crossref] [Google Scholar]
14. 14. 

    Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S 2019. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob. Health 7:394–95
    [Google Scholar]
15. 15. 

    Carlson A, Riethman M, Gastañaduy P, Lee A, Leung J et al. 2019. Community outbreak of measles—Clark County, Washington, 2018–2019. MMWR Morb. Mortal. Wkly. Rep. 68:446–47
    [Google Scholar]
16. 16. 

    Silverman RD. 2019. Controlling measles through policy and politics. Hastings Cent. Rep. 49:8–9
    [Google Scholar]
17. 17. 

    Hoffman BL, Felter EM, Chu K-H, Shensa A, Hermann C et al. 2019. It's not all about autism: the emerging landscape of anti-vaccination sentiment on Facebook. Vaccine 37:2216–23
    [Google Scholar]
18. 18. 

    Zhang S 2019. Why anti-vax doctors are ordering 23 and Me tests. Atlantic May 23. https://www.theatlantic.com/science/archive/2019/05/vaccines-dna-23andme/589915/
    [Google Scholar]
19. 19. 

    DeStefano F, Shimabukuro TT. 2019. The MMR vaccine and autism. Annu. Rev. Virol. 6:583–98
    [Google Scholar]
20. 20. 

    Hviid A, Hansen V, Frisch M, Melbye M 2019. Measles, mumps, rubella vaccination and autism: a nationwide cohort study. Ann. Intern. Med. 170:513–20
    [Google Scholar]
21. 21. 

    Paules CI, Marston HD, Fauci AS 2019. Measles in 2019—going backward. N. Engl. J. Med. 380:2185–87
    [Google Scholar]
22. 22. 

    Graham M, Winter AK, Ferrari M, Grenfell B, Moss WJ et al. 2019. Measles and the canonical path to elimination. Science 364:584–87
    [Google Scholar]
23. 23. 

    Durrheim DN, Andrus JK, Pfaff G, Tabassum S, Bashour H, Githanga D 2019. Eradicating measles: a call for an exceptional coordinated global effort. J. Infect. Dis. In press. https://doi.org/10.1093/infdis/jiz011
    [Crossref] [Google Scholar]
24. 24. 

    Sundaram M, Guterman LB, Omer SB 2019. The true cost of measles outbreaks during the post-elimination era. JAMA 321:1155–56
    [Google Scholar]
25. 25. 

    Han G, Batra N, Vallejo A, Schechter R, Zipprich J et al. 2019. Measles outbreak in an era of stricter immunization requirements—California, March 2018. MMWR Morb. Mortal. Wkly. Rep. 68:201–2
    [Google Scholar]
26. 26. 

    McDonald R, Ruppert PS, Souto M, Johns DE, McKay K et al. 2019. Measles outbreaks from imported cases in orthodox Jewish communities—New York and New Jersey, 2018–2019. MMWR Morb. Mortal. Wkly. Rep. 68:444–45
    [Google Scholar]
27. 27. 

    Indianapolis 500 officials to offer measles vaccine at race. May 23, 2019. AP News https://www.apnews.com/e6d77335bd1648dc99a40dda5b5c8ea5
    [Google Scholar]
28. 28. 

    Schmid P, MacDonald NE, Habersaat K, Butler R 2018. Commentary to: how to respond to vocal vaccine deniers in public. Vaccine 36:196–98
    [Google Scholar]